Research

  • Severe osteoporosis as a manifestation of rare blood disorder

    In an unusual case, a 23-year-old man with severe bone loss and spinal fractures has been found to have systemic mastocytosis (SM) - a rare blood disorder that causes certain immune cells, called mast cells, to build up in different parts of the body. The case highlights how SM can go undiagnosed, and may be [...]

  • Potential new drug target for Alzheimer’s disease uncovered

    A team of researchers has unlocked the details of a cellular pathway that triggers cellular inflammation and ageing and is linked to Alzheimer’s disease, particularly among those who carry the APOE4 genetic risk. They have also found a way to return cells to a healthy state, revealing a new potential approach to treatment. The study [...]

  • Technology for early disease detection under development

    A new biosensor technology is being developed that could transform the early diagnosis and treatment of diseases. The multidisciplinary research project, Next-Generation Molecular Sensors has secured nearly one million euros in funding from the Jane and Aatos Erkko Foundation to support a three-year research initiative. Biosensors play a critical role in healthcare and life sciences, [...]

  • High-precision radiation therapy safe for patients with cancer that has spread – study

    The latest in high-precision radiation therapy has been found to be safe in cancer patients where the disease has spread to more than 10 spots in the body. The findings come from a new phase I clinical trial at the London Health Sciences Centre Research Institute (LHSCRI). Past research from LHSCRI has shown that targeted [...]

  • Strong progress for Faron’s cancer treatment bexmarilimab

    Faron Pharmaceuticals has reported promising results from the latest stage of trials of its immunotherapy-based cancer treatment. The biotech firm has updated on the BEXMAB multi-centre study spanning Finland, the UK and US; which is evaluating the safety and efficacy of its bexmarilimab innovation in patients with aggressive myeloid leukemias. The treatment showed an 80 [...]

  • ECG could be used by AI to detect premature ageing and cognitive decline

    Electrocardiogram (RCG) tests could be use in the future in combination with an AI model to detect premature aging and cognitive decline, according to a new study. An electrocardiogram (ECG) measures the electrical activity of the heartbeat. With each beat, an electrical impulse travels through the heart. Researchers have now designed an AI model, termed [...]

  • Progress in Arctic’s hunt for Alzheimer’s treatment

    The Icelandic drug discovery firm Arctic Therapeutics, which is pioneering new treatments for dementia, has raised €26.5m in investment to advance its work. The new funding will enable the exploration of the potential of AT-001, an oral treatment designed to prevent the aggregation of harmful amyloid proteins in the brain, in other forms of familial [...]

  • How the body’s own ‘bubble wrap’ could aid regenerative medicine

    A new skeletal tissue which has "immense potential" for regenerative medicine and tissue engineering has been identified by researchers. The tissue, known as lipocartilage, is found in the ears, nose and throat of mammals and is composed of fat-filled cells called lipochondrocytes. These cells provide stable internal support, allowing the tissue to remain both soft [...]

  • Age Tech round up: the latest research and developments

    Age Tech World explores the latest developments in the field of age technology and research. AI paves the way for personalised treatments in ageing science A collaborative study has investigated how advanced AI tools, like Large Language Models, can make it easier to evaluate interventions for ageing and provide personalised recommendations. Specifically, the study investigated [...]

  • Investors flock to smart care pioneer Nobi after positive trials

    An agetech venture aiming to revolutionise fall detection and prevention and smart care has raised €35m to advance its mission for ageing well with dignity. Nobi, founded in 2018 by serial entrepreneur and angel investor Roeland Pelgrims, completed the fundraise following promising results for trials of its care sector tech. Its AI smart light, focused [...]